(Q47992098)

7 February 2018

title

Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group. (English)

1 reference

7 February 2018

1 reference

1 reference

3

1 reference

7 February 2018

author name string

Raimund Jakesz

1

1 reference

7 February 2018

Hellmut Samonigg

2

1 reference

7 February 2018

Ernst Kubista

4

1 reference

7 February 2018

Dieter Depisch

5

1 reference

7 February 2018

Roland Kolb

6

1 reference

7 February 2018

Brigitte Mlineritsch

7

1 reference

7 February 2018

Hans-Jörg Mischinger

8

1 reference

7 February 2018

Rainer-Christian Menzel

9

1 reference

7 February 2018

Peter Steindorfer

10

1 reference

7 February 2018

Werner Kwasny

11

1 reference

7 February 2018

Christoph Tausch

12

1 reference

7 February 2018

Michael Stierer

13

1 reference

7 February 2018

Susanne Taucher

14

1 reference

7 February 2018

Michael Seifert

15

1 reference

7 February 2018

Hubert Hausmaninger

16

1 reference

7 February 2018

Austrian Breast & Colorectal Cancer Study Group

17

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 April 2003

1 reference

7 February 2018

published in

Annals of Surgery

1 reference

7 February 2018

volume

237

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

556-564

1 reference

7 February 2018

Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer

cites work

1 reference

12 December 2020

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

12 December 2020

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

12 December 2020

Factors women take into account when deciding upon type of surgery for breast cancer

1 reference

12 December 2020

Geographic variation in the treatment of localized breast cancer

1 reference

12 December 2020

Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute

1 reference

12 December 2020

Randomized trial of adjuvant tamoxifen in node negative postmenopausal breast cancer. Stockholm Breast Cancer Study Group

1 reference

12 December 2020

Are modified radical mastectomies done for T1 breast cancers because of surgeon's advice or patient's choice?

1 reference

12 December 2020

Deciding on breast cancer treatment: a description of decision behavior.

1 reference

12 December 2020

Breast conservation versus mastectomy: patient preferences in a community practice in Kentucky

1 reference

12 December 2020

Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trial. Scottish Cancer Trials Breast Group and ICRF Breast Unit, Guy's Hospital, London

1 reference

12 December 2020

Premenopausal patients with node-positive resectable breast cancer. Preliminary results of a randomised trial comparing 3 adjuvant regimens: FEC 50 x 6 cycles vs FEC 50 x 3 cycles vs FEC 75 x 3 cycles. The French Adjuvant Study Group

1 reference

12 December 2020

Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group

1 reference

12 December 2020

Determinants of receiving breast-conserving surgery. The Surveillance, Epidemiology, and End Results Program, 1983-1986.

1 reference

12 December 2020

Patient selection for breast conservation therapy with magnification mammography

1 reference

12 December 2020

Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: a randomized study

1 reference

12 December 2020

Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

1 reference

12 December 2020

Minimal increase in use of breast-conserving surgery from 1986 to 1990.

1 reference

12 December 2020

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group

1 reference

12 December 2020

Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.

1 reference

12 December 2020

The effect of legislative requirements on the use of breast-conserving surgery

1 reference

12 December 2020

Patient, hospital, and surgeon factors associated with breast conservation surgery. A statewide analysis in North Carolina.

1 reference

12 December 2020

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa

1 reference

12 December 2020

Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience

1 reference

12 December 2020

Use of breast-conserving surgery for treatment of stage I and stage II breast cancer

1 reference

12 December 2020

Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients

1 reference

12 December 2020

It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients

1 reference

12 December 2020

[Therapy studies of the Austrian Breast Cancer Group (ABC)]

1 reference

12 December 2020

Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results

1 reference

12 December 2020

10.1097/00000658-200304000-00018

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

12677153

1 reference

7 February 2018